منابع مشابه
Novel Anti-Tuberculosis Nanodelivery Formulation of Ethambutol with Graphene Oxide.
Tuberculosis (TB) is a bacterial disease responsible for millions of infections and preventable deaths each year. Its treatment is complicated by patients' noncompliance due to dosing frequency, lengthy treatment, and adverse side effects associated with current chemotherapy. However, no modifications to the half-a-century old standard chemotherapy have been made based on a nanoformulation stra...
متن کاملEthambutol in tuberculosis: time to reconsider?
Revision of treatment regimens in Malawi Table 1 shows the regimens used in Malawi for new cases of TB. Having used thiacetazone for approximately 12 years, the Malawi National TB Programme removed it from its essential drug list in January 1997 and substituted ethambutol. Most paediatric cases of TB fall into the category of smear negative pulmonary TB. The proposed new regimen consists of a t...
متن کاملMycobacterium tuberculosis resistance to rifampicin and ethambutol: a clinical survey.
Ninety-seven cultures of Myco, tuberculosis referred to the Tuberculosis Reference Laboratory, Cardiff during 1972-73 and found to be resistant to rifampicin or ethambutol were studied. Resistance to each drug appeared equally common. Few lower grades of rifampicin resistance occurred, cultures tending to be either fully sensitive or highly resistant. Intermediate grades of ethambutol resistanc...
متن کاملAgranulocytosis Induced by Ethambutol in a Patient with Pulmonary Tuberculosis
We report a case of agranulocytosis caused by ethambutol in a 79-year-old man with pulmonary tuberculosis. He was referred for fever and skin rash developed on 21th day after antituberculosis drugs (isoniazid, rifampicin, ethambutol, and pyrazinamide) intake. Complete blood count at the time of diagnosis of pulmonary tuberculosis was normal. On the seventh admission day, agranulocytosis was dev...
متن کاملNew anti-tuberculosis agents amongst known drugs.
Mycobacterium tuberculosis has an on-going impact on global public health and new therapeutics to treat tuberculosis are urgently required. The emergence of drug resistant tuberculosis poses a serious threat to the control of this pathogen, and the development of drugs that are active against the resistant strains is vital. A medium-throughput assay using the Alamar Blue reagent was set-up to i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Tuberculosis and Respiratory Diseases
سال: 1968
ISSN: 1738-3536,2005-6184
DOI: 10.4046/trd.1968.15.1.5